Zhejiang Huahai Pharmaceutical has hired a former FDA staffer as its new chief quality officer, as the company struggles to resolve compliance issues with the FDA at a key manufacturing facility.
A bipartisan bill reintroduced by three senators aims to increase transparency around foreign influence on the United States’ ...
Making a creative pharma campaign that earns recognition at the prestigious Cannes Lions Festival of Creativity is a beast. Gilead Sciences conquered the task with the help of some AI-generated ...
Vanda Pharmaceuticals is sponsoring an IndyCar to fuel awareness of its motion sickness pill Nereus. The biotech backed the ...
As Pfizer and Moderna have tied off certain threads in their separate webs of mRNA patent litigation, Sanofi has opened a new ...
Kelun scores sac-TMT win in first-line NSCLC population missing from Merck’s massive phase 3 program
The clinical blueprint for Merck & Co.’s prized TROP2-directed antibody-drug conjugate, sacituzumab tirumotecan (sac-TMT), ...
In Novo Nordisk and Eli Lilly’s competition to launch their respective GLP-1 obesity pills in the United States, the Danish ...
Red-hot generative AI specialist Insilico Medicine has teamed up with another major biopharma player, this time linking up ...
Merck & Co.’s almighty Keytruda has become the first PD-1 inhibitor to show a benefit as a single agent for the front-line treatment of a subtype of endometrial cancer. | Merck & Co.’s almighty ...
After speedrunning a series of major manufacturing milestones in the past year and a half, the “biotech floodgates” have ...
Huyabio has scored a win in the largest oncology study it has undertaken in its 22 years, as its oral histone deacetylase ...
Nearly a decade after spinning out its Chinese research hub to form Dizal Pharmaceutical, AstraZeneca is paying up to $1.5 billion to buy a piece of the pipeline, securing exclusive global rights for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results